Latanoprost
Latanoprost is a prostaglandin F2α analogue used to reduce elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension. It works by increasing the outflow of aqueous humour through the uveoscleral pathway, thereby lowering pressure inside the eye and helping reduce the risk of optic nerve damage. It is commonly available as a sterile ophthalmic solution, usually administered as eye drops once daily in the affected eye or eyes, as prescribed. Common side effects include eye redness, irritation, stinging, blurred vision, and gradual darkening of iris pigmentation. It may also cause eyelash growth and changes in eyelash thickness or length. Patients should use the drops as directed, avoid touching the dropper tip to the eye, and consult an ophthalmologist if they experience persistent irritation, eye pain, or vision changes.
Latanoprost was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Latanoprost, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Latanoprost from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Latanoprost, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
